| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.044 | 0.8 |